FDA Inspection 1263784 — Fertility Center of Southern California

Fertility Center of Southern California — FEI 3005887264

The FDA completed an inspection of Fertility Center of Southern California on March 14, 2025 in Irvine, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 14, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Irvine, CA (United States)

Citations

IDCFRDescription
1222921 CFR 1271.50(a)Determination based on screening and testing